94021-3 |
Substance use disorder screening report |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Substance use disorder screening report |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
94021-3 |
|
|
|
|
Both |
|
|
|
0 |
SUD screen report |
|
|
|
|
|
Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn; Subs; SUD screen report |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94022-1 |
Depression score |
Score |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Depression score |
|
ADD |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
H&P.HX |
|
94022-1 |
|
|
|
|
Observation |
|
|
|
0 |
Depression score |
|
|
|
|
|
H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale |
2.67 |
2.67 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
94023-9 |
Depression severity |
Imp |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Depression severity |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94023-9 |
|
|
|
|
Observation |
|
|
|
0 |
Depression severity |
|
|
|
|
|
H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94024-7 |
Anxiety score |
Score |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Anxiety score |
|
ADD |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
H&P.HX |
|
94024-7 |
|
|
|
|
Observation |
|
|
|
0 |
Anxiety score |
|
|
|
|
|
H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale |
2.67 |
2.67 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
94025-4 |
Anxiety severity |
Imp |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Anxiety severity |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94025-4 |
|
|
|
|
Observation |
|
|
|
0 |
Anxiety severity |
|
|
|
|
|
H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94026-2 |
Bipolar disorder type |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Bipolar disorder type |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94026-2 |
|
|
|
|
Observation |
|
|
|
0 |
Bipolar type |
|
|
|
|
|
Bipolar type; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94027-0 |
Somatic symptom disorder score |
Score |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Somatic symptom disorder score |
|
ADD |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
H&P.HX |
|
94027-0 |
|
|
|
|
Observation |
|
|
|
0 |
SSD score |
|
|
|
|
|
H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SSD score; Sx |
2.67 |
2.67 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
94028-8 |
Somatic symptom disorder severity |
Imp |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Somatic symptom disorder severity |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94028-8 |
|
|
|
|
Observation |
|
|
|
0 |
SSD severity |
|
|
|
|
|
H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; SSD severity; Sx |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94029-6 |
Substance use disorder score |
Score |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Substance use disorder score |
|
ADD |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
H&P.HX |
|
94029-6 |
|
|
|
|
Observation |
|
|
|
0 |
SUD score |
|
|
|
|
|
H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Subs; SUD score |
2.67 |
2.67 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
9403-7 |
Acylcarnitine |
MCnc |
Urine |
Pt |
Qn |
|
|
DISCOURAGED |
Acylcarnitine [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
9403-7 |
|
|
|
|
Observation |
|
|
|
0 |
Acylcarnitine Ur-mCnc |
|
|
|
Y |
|
Acyl carnitine; Acylcarni; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0i |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
94030-4 |
Substance use disorder severity |
Imp |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Substance use disorder severity |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94030-4 |
|
|
|
|
Observation |
|
|
|
0 |
SUD severity |
|
|
|
|
|
H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Subs; SUD severity |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94031-2 |
ADHD type |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
ADHD type |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94031-2 |
|
|
|
|
Observation |
|
|
|
0 |
ADHD type |
|
|
|
|
|
H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94032-0 |
ADHD inattentive symptoms severity |
Imp |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
ADHD inattentive symptoms severity |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94032-0 |
|
|
|
|
Observation |
|
|
|
0 |
ADHD inattentive severity |
|
|
|
|
|
ADHD inattentive severity; H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Sx |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94033-8 |
ADHD hyperactive symptoms severity |
Imp |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
ADHD hyperactive symptoms severity |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94033-8 |
|
|
|
|
Observation |
|
|
|
0 |
ADHD hyperactive severity |
|
|
|
|
|
ADHD hyperactive severity; H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Sx |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94034-6 |
Suicidal intent |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Suicidal intent |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94034-6 |
|
|
|
|
Observation |
|
|
|
0 |
Suicidal intent |
|
|
|
|
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94035-3 |
Suicide plan |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Suicide plan |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94035-3 |
|
|
|
|
Observation |
|
|
|
0 |
Suicide plan |
|
|
|
|
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94036-1 |
Suicide risk factor |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Suicide risk factor |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94036-1 |
|
|
|
|
Observation |
|
|
|
0 |
Suicide risk factor |
|
|
|
|
|
Fac; Fact; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94037-9 |
Suicidal ideation |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Suicidal ideation |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
94037-9 |
|
|
|
|
Observation |
|
|
|
0 |
Suicidal ideation |
|
|
|
|
|
Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94038-7 |
Substance use disorder question consistency score |
Score |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Substance use disorder question consistency score |
|
ADD |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
H&P.HX |
|
94038-7 |
|
|
|
|
Observation |
|
|
|
0 |
SUD consistency score |
|
|
|
|
|
H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Subs; SUD consistency score |
2.67 |
2.67 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
94039-5 |
ADHD question consistency score |
Score |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
ADHD question consistency score |
|
ADD |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
H&P.HX |
|
94039-5 |
|
|
|
|
Observation |
|
|
|
0 |
ADHD consistency score |
|
|
|
|
|
ADHD consistency score; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale |
2.67 |
2.67 |
|
|
|
|
|
|
|
{score} |
|
|
|
0 |
9404-5 |
Adenosine deaminase |
CCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Adenosine deaminase [Enzymatic activity/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
9404-5 |
|
|
|
|
Both |
|
|
|
0 |
Adenosine deaminase Fld-cCnc |
|
|
|
Y |
|
ADA; ADO; ANED; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Catalytic Concentration; Chemistry; Fl; Fld; FLU; Fluid; Medication stress; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0i |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
94040-3 |
Adenovirus A+B+C+D+E DNA |
PrThr |
Respiratory System Specimen |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Adenovirus A+B+C+D+E DNA [Presence] in Respiratory system specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94040-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HAdV A+B+C+D+E DNA Resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Adeno virus; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; HAdV A+B+C+D+E; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.75 |
2.67 |
|
|
|
|
|
|
|
|
|
|
Release 2.75: SYSTEM: There are 2 similar system's in LOINC: 1- Respiratory system 2- Respiratory specimen Due to an applied logic, the display in the System axis for 1 is Respiratory (adjective) without specification of sample, specimen, or other specific noun, while 2 is displayed fully as Respiratory specimen. Therefore for now we replaced 1 with Respiratory system specimen, which will affect 83 term. The result is replacing "Respiratory" with "Respiratory system specimen". This is the short approach. The bigger project is to potentially merge data that has either 1 or 2 together. This is a project to pass by the laboratory committee and will involve about 1500 concepts.; |
0 |
94041-1 |
My practice makes it easy for me to get care |
Find |
^Patient |
Pt |
Ord |
PCPCM |
|
ACTIVE |
My practice makes it easy for me to get care [PCPCM] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
94041-1 |
|
PCPCM |
|
|
Observation |
|
|
|
0 |
|
|
PCPCM.Q1 |
My practice makes it easy for me to get care. |
|
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94042-9 |
My practice is able to provide most of my care |
Find |
^Patient |
Pt |
Ord |
PCPCM |
|
ACTIVE |
My practice is able to provide most of my care [PCPCM] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
94042-9 |
|
PCPCM |
|
|
Observation |
|
|
|
0 |
|
|
PCPCM.Q2 |
My practice is able to provide most of my care. |
|
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94043-7 |
In caring for me, my doctor considers all the factors that affect my health |
Find |
^Patient |
Pt |
Ord |
PCPCM |
|
ACTIVE |
In caring for me, my doctor considers all the factors that affect my health [PCPCM] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.GNHLTH |
|
94043-7 |
|
PCPCM |
|
|
Observation |
|
|
|
0 |
|
|
PCPCM.Q3 |
In caring for me, my doctor considers all the factors that affect my health. |
|
|
Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |